Milliflex® Rapid System To Test Cell-Based Immunotherapeutics For Microbial Contaminants

Immunotherapy, an established cancer treatment, often uses activated T cells. While swift release is vital for optimal efficacy, ensuring microbiological safety is equally crucial. The Milliflex® Rapid System, an automated ATP-based system, swiftly detects images and quantifies viable microbial contaminants in filterable samples during manufacturing. By prioritizing microbiological safety, it streamlines the production and release process, ensuring patient safety while expediting treatment availability.